Compare CORT & COLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CORT | COLB |
|---|---|---|
| Founded | 1998 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 9.2B |
| IPO Year | 2001 | 1996 |
| Metric | CORT | COLB |
|---|---|---|
| Price | $113.79 | $30.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 14 |
| Target Price | ★ $96.50 | $31.46 |
| AVG Volume (30 Days) | 823.3K | ★ 2.6M |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 5.08% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.09 | ★ 1.38 |
| Revenue | ★ $761,407,000.00 | $177,000,000.00 |
| Revenue This Year | $26.08 | $31.52 |
| Revenue Next Year | $26.98 | $2.90 |
| P/E Ratio | $1,224.56 | ★ $21.66 |
| Revenue Growth | 12.79 | ★ 18.94 |
| 52 Week Low | $28.66 | $23.83 |
| 52 Week High | $126.38 | $33.68 |
| Indicator | CORT | COLB |
|---|---|---|
| Relative Strength Index (RSI) | 52.88 | 43.79 |
| Support Level | $108.25 | $29.77 |
| Resistance Level | $124.30 | $30.00 |
| Average True Range (ATR) | 5.29 | 0.67 |
| MACD | -0.76 | 0.02 |
| Stochastic Oscillator | 61.04 | 47.25 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.